SkinHealth Systems (SKIN) Cost of Revenue (2020 - 2026)

SkinHealth Systems (SKIN) has reported Cost of Revenue for 7 consecutive years, with $22.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 21.67% year-over-year to $22.8 million in Q2 2026; TTM through Jun 2026 was $97.6 million, a 18.24% decrease from a year earlier, with the FY2025 full-year figure at $104.4 million, down 31.3% from the prior year.
• Cost of Revenue was $22.8 million for Q2 2026 at SkinHealth Systems, up from $20.5 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $110.0 million in Q3 2023 and troughed at $20.5 million in Q1 2026.
• A 5-year average of $36.6 million and a median of $31.4 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 300.91% in 2023 and plunged 65.3% in 2024, its largest moves.
• Over 5 years, Cost of Revenue stood at $31.6 million in 2022, then surged by 61.6% to $51.1 million in 2023, then plunged by 39.08% to $31.1 million in 2024, then decreased by 5.84% to $29.3 million in 2025, then retreated by 22.35% to $22.8 million in 2026.
• The last three Cost of Revenue figures came in at $22.8 million (Q2 2026), $20.5 million (Q1 2026), and $29.3 million (Q4 2025), per Business Quant data.